Rallybio Corporation
Price
FilingsNewest: 8-K, Director or officer changeSep 9 →Insiders2 insiders bought $4.2M in 14 open-market buys. 1 insider sold $3,992 in 1 sale, with no 10b5-1 plan named.→HoldersAdar1 17.5%Citadel $12.7MFMR 15.0%→Financing →PeersClosest companies: RVMD, FULC, CMPX→
From the filings
Figures
- Revenue
- $646,000last 12 months
- Net income
- $45.6Mlast 12 months
- Operating cash flow
- −$27.6Mlast 12 months
- Cash and equivalents
- $92.8Mat the last balance sheet
- Shares outstanding
- 5.3M shareson issue